Tag: Sarah Rutstein

Antiretroviral therapy (ART) for viral suppression in people living with HIV (PWH) improves life expectancy and interrupts transmission. And new long-acting ART injectables have become a convenient treatment, helping overcome the burden of pills and the stigma associated with taking daily medication. But while there has been a 68% reduction...

“We at the Institute for Global Health and infectious diseases are a large community of multi-disciplinary investigators,” said Sonia Napravnik, PhD, in her webinar welcome message during University Research Week. “And essentially, we all focus on improving health globally and locally, here in North Carolina and across the US.” “Our...

HIV index case testing (ICT) aims to identify people living with HIV and their contacts, engage them in HIV testing services, and link them to care. Enhancing capacity through centralized face-to-face training is logistically complex and expensive. A decentralized blended learning approach to HCW capacity-building, combining synchronous face-to-face and asynchronous...

Retention and adherence to daily oral pre-exposure prophylaxis (PrEP) are critical for effective HIV prevention; however, YMSM exhibit lower rates of both compared to other populations. This is important because young men who have sex with men (YMSM) are at higher risk for HIV, and understanding their challenges can help...

The earliest months of HIV infection are characterized by high viral loads and elevated transmissibility, particularly during the acute (preseroconversion) phase. Transmission prevention during early HIV requires diagnostic tools that narrow the window between viral acquisition and a reactive test, followed by rapid linkage to effective antiretroviral therapy (ART). Sarah...

Pre-exposure prophylaxis (PrEP) is an important tool for reducing HIV incidence in the United States, but barriers to access, including race, sex, socioeconomic status, and geography, continue to persist. Sarah E. Rutstein, MD, PhD, Assistant Professor of Medicine, Christopher Hurt, MD, FIDSA, Professor of Medicine, and Brian Wells Pence, PhD, Professor of Epidemiology are conducting a study...

Investigators with the Institute for Global Health and Infectious Diseases (IGHID) participated in the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, California, March 9-12. Following are some highlights.   In a CROI preview, Joe Eron, MD, was interviewed for the “Going Anti-Viral” IAS-USA podcast, discussing the...

Led by Mina Hosseinipour, MD, MPH, the NIH’s National Institute of Child Health and Human Development (NICHD), has funded the project “Preventing Infant Infections with Implementation Science in Malawi.” (PRI3SM). The program, in partnership with the Republic of Malawi’s Ministry of Health, comprises three studies to address gaps in prevention services,...